The objective of this systematic review and meta-analysis was twofold: to answer the question “What is the evidence for the effectiveness of prophylactic intravenous antibiotics for infection prevention in shunt surgery?” and to make treatment recommendations based on the available evidence.
The US National Library of Medicine PubMed/MEDLINE database and the Cochrane Database of Systematic Reviews were queried using MeSH headings and key words relevant to prophylactic antibiotic use in children undergoing a shunt operation. Abstracts were reviewed to identify which studies met the inclusion criteria. An evidentiary table was assembled summarizing the studies and the quality of evidence (Classes I-III). A meta-analysis was conducted using a random-effects model to calculate a cumulative estimate of treatment effect using risk ratio (RR). Heterogeneity was assessed using chi-square and I2 statistics. A sensitivity analysis was also conducted. Based on the quality of the literature and the result of the meta-analysis, a recommendation was rendered (Level I, II, or III).
Nine studies (4 Class I, 3 Class II, and 2 Class III) met our inclusion criteria. Of 7 randomized controlled trials (RCTs), 3 were downgraded from Class I to Class II because of significant quality issues, and all RCTs were potentially underpowered. In only 2 Class in retrospective cohort studies were preoperative antibiotic agents found to be protective against shunt infection. When data from the individual studies were pooled together, the infection rate in the prophylactic antibiotics group was 5.9% compared with 10.7% in the control group. Using a random-effects model, the cumulative RR was 0.55 (95% CI 0.38–0.81), indicating a protective benefit of prophylactic preoperative intravenous antibiotics. A sensitivity analysis of RCTs only (n = 7) also demonstrated a statistical benefit, but an analysis of higher-quality RCTs only (n = 4) did not.
Within the limits of this systematic review and meta-analysis, administration of preoperative antibiotic agents for shunt surgery in children was found to lower the infection risk (quality of evidence: Class II; strength of recommendation, Level II).
The use of preoperative antibiotic agents can be recommended to prevent shunt infection in patients with hydrocephalus. It was only by combining the results of the various underpowered studies (meta-analysis) that the use of preoperative antibiotics for shunt surgery in children was shown to lower the risk of shunt infection. Strength of Recommendation: Level II, moderate degree of clinical certainty.
Disclosure The systematic review and evidence-based guidelines were funded exclusively by the CNS and AANS Pediatric Section, which received no funding from outside commercial sources to support the development of this document.
Conflict(s) of Interest: None. All Task Force members declared any potential conflicts of interest prior to beginning work on this evidence review.
Author contributions to the study and manuscript preparation include the following. Conception and design: AANS/CNS Joint Section on Pediatrics. Acquisition of data: all authors. Analysis and interpretation of data: all authors. Drafting the article: Klimo. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Flannery. Statistical analysis: all authors. Administrative/technical/material support: all authors. Study supervision: Flannery.
Please include this information when citing this paper: DOI: 10.3171/2014.7.PEDS14326.
Ajir F, , Levin AB, & Duff TA: Effect of prophylactic methicillin on cerebrospinal fluid shunt infections in children. Neurosurgery 9:6–8, 1981
Arnaboldi L: Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures. A prospective study of 100 patients undergoing shunt operations. Chemotherapy 42:384–390, 1996
Attenello FJ, , Garces-Ambrossi GL, , Zaidi HA, , Sciubba DM, & Jallo GI: Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 66:284–289, 2010
Barker FG II: Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery 51:391–401, 2002
Barker FG II: Efficacy of prophylactic antibiotics against meningitis after craniotomy: a meta-analysis. Neurosurgery 60:887–894, 2007
Barker FG II: Efficacy of prophylactic antibiotics for craniotomy: a meta-analysis. Neurosurgery 35:484–492, 1994
Bayston R: Antibiotic prophylaxis in shunt surgery. Dev Med Child Neurol Suppl 17:99–103, 1975
Bayston R, , Bannister C, , Boston V, , Burman R, , Burns B, & Cooke F, et al.: A prospective randomised controlled trial of antimicrobial prophylaxis in hydrocephalus shunt surgery. Z Kinderchir 45:Suppl 1 5–7, 1990
Biyani N, , Grisaru-Soen G, , Steinbok P, , Sgouros S, & Constantini S: Prophylactic antibiotics in pediatric shunt surgery. Childs Nerv Syst 22:1465–1471, 2006
Blomstedt GC: Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial. J Neurosurg 62:694–697, 1985
Blum J, , Schwarz M, & Voth D: Antibiotic single-dose prophylaxis of shunt infections. Neurosurg Rev 12:239–244, 1989
Bullock R, , van Dellen JR, , Ketelbey W, & Reinach SG: A double-blind placebo-controlled trial of perioperative prophylactic antibiotics for elective neurosurgery. J Neurosurg 69:687–691, 1988
Chadduck W, & Adametz J: Incidence of seizures in patients with myelomeningocele: a multifactorial analysis. Surg Neurol 30:281–285, 1988
Crowther M, , Lim W, & Crowther MA: Systematic review and meta-analysis methodology. Blood 116:3140–3146, 2010
Darouiche RO: Treatment of infections associated with surgical implants. N Engl J Med 350:1422–1429, 2004
Deeks JJ, , Higgins JPT, & Altman DG, Chapter 9: Analysing data and undertaking meta-analyses. Higgins JPT, & Green S: Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 The Cochrane Collaboration, 2011
DerSimonian R, & Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177–188, 1986
Djindjian M, , Fevrier MJ, , Otterbein G, & Soussy JC: Oxacillin prophylaxis in cerebrospinal fluid shunt procedures: results of a randomized open study in 60 hydrocephalic patients. Surg Neurol 25:178–180, 1986
George R, , Leibrock L, & Epstein M: Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804–811, 1979
Haines SJ, & Taylor F: Prophylactic methicillin for shunt operations: effects on incidence of shunt malfunction and infection. Childs Brain 9:10–22, 1982
Haines SJ, & Walters BC: Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery 34:87–92, 1994
Jamjoom AB, , Mohammed AA, , al-Boukai A, , Jamjoom ZA, , Rahman N, & Jamjoom HT: Multiloculated hydrocephalus related to cerebrospinal fluid shunt infection. Acta Neurochir (Wien) 138:714–719, 1996
Kestle JR, , Hoffman HJ, , Soloniuk D, , Humphreys RP, , Drake JM, & Hendrick EB: A concerted effort to prevent shunt infection. Childs Nerv Syst 9:163–165, 1993
Langley JM, , LeBlanc JC, , Drake J, & Milner R: Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 17:98–103, 1993
Mapstone TB, , Rekate HL, , Nulsen FE, , Dixon MS Jr, , Glaser N, & Jaffe M: Relationship of CSF shunting and IQ in children with myelomeningocele: a retrospective analysis. Childs Brain 11:112–118, 1984
McCullough DC, , Kane JG, , Harleman G, & Wells M: Antibiotic prophylaxis in ventricular shunt surgery. II. Antibiotic concentrations in cerebrospinal fluid. Childs Brain 7:190–194, 1980
Odio C, , Mohs E, , Sklar FH, , Nelson JD, & McCracken GH Jr: Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. Am J Dis Child 138:17–19, 1984
Prusseit J, , Simon M, , von der Brelie C, , Heep A, , Molitor E, & Volz S, et al.: Epidemiology, prevention and management of VP shunt infections in children. Pediatr Neurosurg 45:325–336, 2009
Ratilal B, , Costa J, & Sampaio C: Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatr 1:48–56, 2008
Rieder MJ, , Frewen TC, , Del Maestro RF, , Coyle A, & Lovell S: The effect of cephalothin prophylaxis on postoperative ven-triculoperitoneal shunt infections. CMAJ 136:935–938, 1987
Schmidt K, , Gjerris F, , Osgaard O, , Hvidberg EF, , Kristiansen JE, & Dahlerup B, et al.: Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 152 hydrocephalic patients. Neurosurgery 17:1–5, 1985
Schoenbaum SC, , Gardner P, & Shillito J: Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 131:543–552, 1975
Simon TD, , Hall M, , Dean JM, , Kestle JR, & Riva-Cambrin J: Reinfection following initial cerebrospinal fluid shunt infection. Clinical article. J Neurosurg Pediatr 6:277–285, 2010
Simon TD, , Hall M, , Riva-Cambrin J, , Albert JE, , Jeffries HE, & Lafleur B, et al.: Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr 4:156–165, 2009
Simon TD, , Riva-Cambrin J, , Srivastava R, , Bratton SL, , Dean JM, & Kestle JR: Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr 1:131–137, 2008
Simon TD, , Whitlock KB, , Riva-Cambrin J, , Kestle JR, , Rosen-feld M, & Dean JM, et al.: Revision surgeries are associated with significant increased risk of subsequent cerebrospinal fluid shunt infection. Pediatr Infect Dis J 31:551–556, 2012
Vanaclocha V, , Sáiz-Sapena N, & Leiva J: Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 138:829–834, 1996
Viano JC, , Tregnaghi M, , Casagnas M, & Suárez JC: Valvular infections in patients with hydrocephalus: preventive aspects. Childs Nerv Syst 6:397–399, 1990
Walters BC, , Goumnerova L, , Hoffman HJ, , Hendrick EB, , Humphreys RP, & Levinton C: A randomized controlled trial of perioperative rifampin/trimethoprim in cerebrospinal fluid shunt surgery. Childs Nerv Syst 8:253–257, 1992
Wang EE, , Prober CG, , Hendrick BE, , Hoffman HJ, & Humphreys RP: Prophylactic sulfamethoxazole and trimethoprim in ven-triculoperitoneal shunt surgery. A double-blind, randomized, placebo-controlled trial. JAMA 251:1174–1177, 1984
Weiss SR, & Raskind R: Further experience with the ventriculo-peritoneal shunt. Prophylactic antibiotics. Int Surg 53:300–303, 1970
Wong JM, , Ziewacz JE, , Ho AL, , Panchmatia JR, , Bader AM, & Garton HJ, et al.: Patterns in neurosurgical adverse events: cerebrospinal fluid shunt surgery. Neurosurg Focus 33:5 E13, 2012
Young RF, & Lawner PM: Perioperative antibiotic prophylaxis for prevention of postoperative neurosurgical infections. A randomized clinical trial. J Neurosurg 66:701–705, 1987
Yu HC, & Patterson RH Jr: Prophylactic antimicrobial agents after ventriculoatriostomy for hydrocephalus. J Pediatr Surg 8:881–885, 1973
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1194 | 768 | 42 |
| Full Text Views | 2471 | 66 | 11 |
| PDF Downloads | 2646 | 92 | 9 |
| EPUB Downloads | 0 | 0 | 0 |